ABSI - Absci Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.05
DETAILS
HIGH:
$8.00
LOW:
$4.10
MEDIAN:
$6.05
CONSENSUS:
$6.05
UPSIDE:
18.63%
About Absci Corporation (https://www.absci.com)
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Sean McClain | Founder, Chief Executive Officer, President & Director | 1990 | $1,076,501 USD |
| Zachariah Jonasson | Chief Business Officer & Chief Financial Officer | 1973 | $816,507 USD |
| Alexander Khan | CVP of Finance & Head of Investor Relations | – | – |
| Amer-Denis Akkad | Vice President of Research | – | – |
| Amir Shanehsazzadeh | Chief AI Officer | – | – |
| Anders Kassow | Head of Intellectual Property | – | – |
| Christine Lemke | Senior Vice President of Portfolio & Growth Strategy | – | – |
| Jeanne Schreuder SPHR | Senior Vice President of People & Experience | – | – |
| Karin Wierinck | Chief People Officer | – | – |
| Melissa Patterson | Chief of Staff | – | – |
| Ransi Somaratne FACC | Chief Medical Officer | 1966 | – |
| Shelby Walker | Chief Legal Officer | 1975 | – |
| Todd Bedrick | Senior Vice President & Chief Accounting Officer | – | – |
| Wen Sha | Chief of Staff | – | – |